Electrophoresis Equipment and Supplies Market

Electrophoresis Equipment and Supplies Market Forecast By Fact.MR

In 2025, the electrophoresis equipment and supplies market was valued at USD 2.3 billion. Based on Fact MR's analysis, demand for electrophoresis equipment and supplies is estimated to grow to USD 2.4 billion in 2026 and USD 3.8 billion by 2036. FMR projects a CAGR of 4.8% during the forecast period.

The absolute dollar growth from 2026 to 2036 is USD 1.4 billion. This growth is driven by increasing demand for molecular biology research, clinical diagnostics, and biotechnology applications. Electrophoresis equipment is critical for DNA, RNA, and protein analysis, supporting drug development, genetic research, and disease diagnostics. However, high costs of advanced equipment and regulatory compliance requirements may limit growth in certain regions.

China leads with a CAGR of 6.5%, driven by increasing biotech research and growing pharmaceutical manufacturing. India follows with 6.1%, supported by rising investments in life sciences and clinical diagnostics. South Korea grows at 5.6%, reflecting demand in advanced research institutions and biotech industries. The USA shows a CAGR of 4.2%, fueled by steady adoption in academic and commercial laboratories. Germany grows at 3.8%, driven by consistent demand in research and diagnostics applications.

Electrophoresis Equipment and Supplies Market

Electrophoresis Equipment and Supplies Market Definition

The Electrophoresis Equipment and Supplies Market involves the manufacture and sale of instruments, consumables, and accessories used to separate macromolecules such as DNA, RNA, and proteins based on size or charge in research, clinical, and industrial laboratories.

Market Inclusions

This report covers global and regional market sizes for electrophoresis equipment and supplies over a defined forecast period, including product categories (gel electrophoresis units, capillary electrophoresis systems, power supplies), consumables (gels, buffers, plates), and end‑use settings (academic & research, pharmaceutical & biotech, clinical diagnostics).

Market Exclusions

The scope excludes unrelated laboratory instruments not specific to electrophoresis, general chromatography systems, and reagents without dedicated electrophoresis application.

Research Methodology

• Primary Research: Interviews were conducted with laboratory scientists, equipment manufacturers, and procurement specialists.
• Desk Research: Data was sourced from scientific publications, industry reports, and trade association statistics.
• Market‑Sizing and Forecasting: A hybrid model combining top‑down life science research and diagnostics demand forecasts with bottom‑up shipment and revenue data was used.
• Data Validation and Update Cycle: Findings were validated through expert review and aligned with recent production, adoption, and trade figures.

Summary of the Electrophoresis Equipment and Supplies Market

• Market Definition
  • The Electrophoresis Equipment and Supplies Market involves global production, trade, and sale of gel and capillary electrophoresis systems, consumables, reagents, and software used for the separation, analysis, and purification of DNA, RNA, and proteins. Applications include research, clinical diagnostics, quality control, and process validation in pharmaceutical, biotechnology, and academic laboratories.
• Demand Drivers
  • Rising global investment in molecular biology, genomics, and proteomics research.
  • Increasing adoption of advanced diagnostics and clinical laboratory workflows.
  • Expansion of biotechnology and pharmaceutical research infrastructure.
  • Demand for high-resolution, reproducible, and automated biomolecule separation.
  • Regulatory requirements and quality standards in diagnostic and research applications.
• Key Segments Analyzed
  • Product Type: Gel Electrophoresis Systems (59% share in 2026), Capillary Electrophoresis Systems, Reagents & Consumables, Software.
  • Application: Research (43% share in 2026), Diagnostic, Quality Control & Process Validation.
  • End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Forensic Laboratories.
  • Geography: North America, Europe, East Asia, South Asia; China shows the highest CAGR at 6.5%, followed by India (6.1%), South Korea (5.6%), USA (4.2%), and Germany (3.8%).
• Analyst Opinion at Fact MR
  • Shambhu Nath Jha, Principal Consultant, Fact MR, states, “The electrophoresis equipment and supplies market continues to expand as molecular biology, diagnostics, and biotech research grow globally. Gel electrophoresis remains dominant due to affordability, reliability, and compatibility with standard workflows. Providers offering integrated instruments, reagents, and software solutions that support high-resolution separation, reproducibility, and regulatory compliance will maintain competitive advantage. Growth is tied to R&D expansion, clinical adoption, and automation trends rather than replacement of legacy systems alone.”
• Strategic Implications/Executive Takeaways
  • Focus on integrated electrophoresis platforms combining hardware, software, and consumables.
  • Target high-growth markets such as China, India, and South Korea with research infrastructure expansion.
  • Provide certified, compliant systems to meet regulatory standards in diagnostics and pharmaceuticals.
  • Expand service and support networks to address adoption barriers in emerging markets.
  • Offer automated and high-throughput systems to improve accuracy, reproducibility, and workflow efficiency.
• Methodology
  • Primary Research: Interviews with laboratory scientists, equipment manufacturers, and procurement specialists.
  • Desk Research: Data sourced from scientific publications, trade reports, and industry associations.
  • Market Sizing & Forecasting: Hybrid top-down and bottom-up modeling using research and sales data.
  • Data Validation: Findings validated through expert review, adoption data, and proprietary Fact MR forecasting models.

Segmental Analysis

Electrophoresis Equipment and Supplies Market Analysis by Product Type

Market Overview: Gel electrophoresis systems are expected to capture 59% of the market share by 2026. Gel electrophoresis is widely used in laboratories for separating and analyzing DNA, RNA, and proteins. Its ease of use, cost-effectiveness, and suitability for routine molecular biology workflows make it the dominant product type.

Demand Drivers:

• Extensive Research Applications: Gel electrophoresis is essential for molecular biology, genetics, and biochemistry research, driving strong adoption in academic and industrial labs.
• Cost-Effective and Reliable: Gel systems offer reliable separation with lower operational costs compared to more advanced techniques, supporting widespread use.
• Compatibility with Downstream Analysis: Gel electrophoresis facilitates visualization and quantification of biomolecules, making it integral to workflows in diagnostics and research applications.

Electrophoresis Equipment and Supplies Market Analysis by Application

Market Overview: Research applications are projected to hold 43% of the market share by 2026. Electrophoresis equipment is extensively used in research labs for gene expression studies, protein analysis, and biomolecular characterization, supporting scientific discovery and innovation.

Demand Drivers:

• Growth in Molecular Biology Research: Rising investments in life sciences research, genomics, and proteomics increase demand for electrophoresis systems and supplies.
• Academic and Industrial Adoption: Universities, research institutions, and biotech companies widely adopt electrophoresis techniques for routine and advanced experiments.
• Support for Diagnostic and Quality Control Studies: Beyond research, electrophoresis tools are also used for diagnostics and process validation, supporting accuracy and compliance in laboratories.

Electrophoresis Equipment and Supplies Market Drivers, Restraints, and Opportunities

FMR analysts observe that the electrophoresis equipment and supplies market is a growth‑aligned, life‑sciences segment driven by rising demand for precise biomolecule separation in research, clinical diagnostics, and pharmaceutical development. Historically, gel electrophoresis served basic separation needs; as genomics, proteomics, and biopharmaceutical analysis expanded, structural demand emerged for advanced electrophoresis systems and consumables that deliver higher resolution, throughput, and automation. The 2026 valuation reflects this shift, with adoption tied to broader R&D activity, clinical workflows, and quality assurance requirements rather than legacy manual methods alone.

While traditional manual gel systems remain in use in cost‑sensitive labs, advanced automated and high‑throughput electrophoresis platforms are gaining share because they improve accuracy, reproducibility, and workflow efficiency. These premium instruments and supplies command higher per‑unit prices, contributing to net market value growth even as unit volumes grow moderately with laboratory expansion. The market exists because electrophoretic separation remains foundational to molecular analysis and regulatory/quality standards increasingly favor validated, performance‑rated systems.

• R&D and Clinical Demand: Research institutions and clinical labs adopt advanced electrophoresis to replace basic systems for high‑resolution, reproducible separation in genomics and proteomics workflows.
• Standards & Regulatory Pressure: Quality and compliance standards in diagnostics and pharmaceutical assays push use of certified electrophoresis equipment and consumables that meet defined performance criteria.
• Regional Laboratory Growth: In North America and Europe, strong life‑science research and clinical infrastructure drive higher uptake of advanced systems, while Asia‑Pacific shows rapid growth with expanding lab capabilities.

Regional Analysis

The market analysis covers key global regions, including North America, Europe, East Asia, and South Asia. It is segmented geographically, with specific market dynamics for each region. The full report provides a detailed market attractiveness analysis.

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research

North America

The USA is a major market, driven by academic research, clinical diagnostics, and pharmaceutical R&D. Key players include Thermo Fisher Scientific, Bio-Rad Laboratories, and Agilent Technologies.

• USA: Demand for electrophoresis equipment and supplies in the U.S. is projected to rise at 4.2% CAGR through 2036. Growth is supported by federal research funding programs (05-2025) and Thermo Fisher Scientific’s regional product expansion (09-2025).

Europe

Germany is a leading market, supported by pharmaceutical R&D, academic institutions, and biotechnology applications.

• • Germany: Demand for electrophoresis equipment and supplies in Germany is projected to rise at 3.8% CAGR through 2036. Growth is influenced by national research grants (04-2025) and Bio-Rad Laboratories’ regional distribution expansions (08-2025).

East Asia

China and South Korea are key markets, driven by increasing biotech and pharmaceutical research activities.

• China: Demand for electrophoresis equipment and supplies in China is projected to rise at 6.5% CAGR through 2036. Growth is supported by government-funded research programs (03-2025) and Agilent Technologies’ regional facility expansion (07-2025).
• South Korea: Demand for electrophoresis equipment and supplies in South Korea is projected to rise at 5.6% CAGR through 2036. Growth is influenced by biotechnology research initiatives (02-2025) and local distribution network expansions by Thermo Fisher Scientific (06-2025).

South Asia

India is a significant market, supported by growing academic and pharmaceutical research, as well as biotechnology industry expansion.

• India: Demand for electrophoresis equipment and supplies in India is projected to rise at 6.1% CAGR through 2036. Growth is driven by government research grants (05-2025) and Bio-Rad Laboratories’ regional expansions (09-2025).

Fact MR's analysis of the electrophoresis equipment and supplies market in North America, Europe, East Asia, and South Asia consists of country-wise assessments that include the USA, Germany, China, India, and South Korea. Readers can find detailed trends, regulatory updates, and company-specific investments shaping market growth in these countries.

What is the Competitive Structure and Buyer Behavior in the Electrophoresis Equipment and Supplies Market?

The electrophoresis equipment and supplies market is moderately concentrated, with major life sciences and analytical instrument firms such as Thermo Fisher Scientific Inc., Bio‑Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Danaher Corporation, and Shimadzu Corporation capturing significant share alongside established suppliers including PerkinElmer, Inc., QIAGEN N.V., Cleaver Scientific Ltd., and Takara Bio Inc. The primary competitive variables are instrument performance, resolution and reproducibility, compatibility with molecular biology workflows, and comprehensive reagent and consumable support, all of which influence procurement by research laboratories, clinical diagnostics facilities, and industrial life sciences users.

Companies with broad product portfolios, deep R&D capabilities, and global service and support networks hold structural advantages because they can offer integrated solutions, ensure regulatory compliance, and provide responsive technical assistance. Large institutional buyers such as universities, pharmaceutical companies, and government labs exert notable leverage by qualifying multiple suppliers, negotiating long‑term agreements, and standardising specifications tied to performance and quality outcomes. To manage supplier dependency, these buyers maintain diversified vendor lists and emphasise reliability and service responsiveness, which limits individual suppliers’ pricing power. As a result, competition centers on delivering robust performance, reliable supply of consumables, and strong after‑sales support rather than on price alone.

Key Players of the Electrophoresis Equipment and Supplies Market

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Danaher Corporation
• Shimadzu Corporation
• PerkinElmer, Inc.
• QIAGEN N.V.
• Cleaver Scientific Ltd.
• Takara Bio Inc.

Report Scope

Bibliographies

• StatPearls Publishing. (2025). Electrophoresis. In StatPearls. StatPearls Publishing.
• Tramini, J. (2023, October 5). Electrophoresis in molecular biology: Principles and applications. Journal of Biological Research and Therapy.
• Johnson, R. (2023). Understanding electrophoresis: Principles and applications. Journal of Clinical and Bioanalytical Chemistry, 7(4).
• Biocompare. (2024, August 19). Electrophoresis equipment. Biocompare.

This report addresses

• Market intelligence enabling evaluation of global electrophoresis equipment and supplies by product type (gel electrophoresis systems, capillary electrophoresis systems, reagents & consumables, software), application (research, diagnostic, quality control & process validation), and end users (pharmaceutical & biotechnology companies, academic & research institutes, diagnostic laboratories, forensic laboratories).
• Market volume (revenue) estimates and 10-year forecasts from 2026 to 2036, validated using trends in molecular biology research, biotechnology adoption, and clinical diagnostics.
• Growth opportunity mapping across product types, applications, and end-user segments, with major markets including China, India, USA, South Korea, and Germany.
• Segment and regional revenue forecasts for gel systems, capillary systems, consumables, and software, including adoption in research, diagnostic, and quality control workflows.
• Competitive strategy analysis highlighting instrument performance, resolution, reproducibility, workflow compatibility, reagent and consumable support, and service infrastructure, with major players including Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Merck KGaA, Danaher Corporation, Shimadzu Corporation, PerkinElmer, Inc., QIAGEN N.V., Cleaver Scientific Ltd., and Takara Bio Inc.
• Adoption dynamics emphasizing academic, industrial, and clinical laboratories implementing electrophoresis equipment and supplies for molecular separation, biomolecular analysis, and diagnostics to support R&D, quality control, and regulatory compliance.
• Report delivery in PDF, Excel, PowerPoint, and interactive dashboard formats suitable for executive, operational, and strategic planning.